ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
0.2010
+0.0008 (0.40%)
At close: Sep 26, 2025, 4:00 PM EDT
0.2001
-0.0009 (-0.45%)
After-hours: Sep 26, 2025, 7:54 PM EDT
ESSA Pharma Employees
ESSA Pharma had 35 employees as of September 30, 2024. The number of employees decreased by 15 or -30.00% compared to the previous year.
Employees
35
Change (1Y)
-15
Growth (1Y)
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$721,863
Market Cap
9.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EPIX News
- 3 days ago - ESSA Pharma Inc. Amends Agreement with XenoTherapeutics - PRNewsWire
- 17 days ago - Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025 - PRNewsWire
- 4 weeks ago - Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution - PRNewsWire
- 6 weeks ago - Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution - PRNewsWire
- 7 weeks ago - Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders - PRNewsWire
- 2 months ago - ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders - PRNewsWire
- 2 months ago - ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction - PRNewsWire
- 5 months ago - ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - PRNewsWire